Analysis of acquired resistance to metronomic oral topotecan chemotherapy plus pazopanib after prolonged preclinical potent responsiveness in advanced ovarian cancer.
about
FL118, a novel camptothecin analogue, overcomes irinotecan and topotecan resistance in human tumor xenograft models.Dual Metronomic Chemotherapy with Nab-Paclitaxel and Topotecan Has Potent Antiangiogenic Activity in Ovarian Cancer.Potent efficacy of metronomic topotecan and pazopanib combination therapy in preclinical models of primary or late stage metastatic triple-negative breast cancer.Nanometronomic treatment of 4T1 breast cancer with nanocaged doxorubicin prevents drug resistance and circumvents cardiotoxicity.Resistance to metronomic chemotherapy and ways to overcome it.Metronomic chemotherapy for triple negative breast cancer?In Vivo Assessment of Ovarian Tumor Response to Tyrosine Kinase Inhibitor Pazopanib by Using Hyperpolarized 13C-Pyruvate MR Spectroscopy and 18F-FDG PET/CT Imaging in a Mouse Model.Local Radiotherapy Affects Drug Pharmacokinetics-Exploration of a Neglected but Significant Uncertainty of Cancer Therapy.
P2860
Q36309467-D09ED9F2-4788-4151-B4AA-9E5AE2F17EA8Q36359684-AB8D1CF1-206F-472E-A905-9F9EAFB23081Q36618871-1D422E91-A02C-4AA2-8697-1D2C9C2416D6Q37702718-DFB65DB2-5798-474A-8808-BC3791D98E82Q40448516-2C7ED12A-5779-4AB9-8599-44C1006003E9Q42523304-82716F59-C790-4450-B641-B17CC96F6CB0Q47698844-45888387-9554-4655-85DF-D0446006F5B7Q50052519-AFD7B44B-73B7-46BA-B319-75EFC0954AC4
P2860
Analysis of acquired resistance to metronomic oral topotecan chemotherapy plus pazopanib after prolonged preclinical potent responsiveness in advanced ovarian cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Analysis of acquired resistanc ...... ss in advanced ovarian cancer.
@ast
Analysis of acquired resistanc ...... ss in advanced ovarian cancer.
@en
type
label
Analysis of acquired resistanc ...... ss in advanced ovarian cancer.
@ast
Analysis of acquired resistanc ...... ss in advanced ovarian cancer.
@en
prefLabel
Analysis of acquired resistanc ...... ss in advanced ovarian cancer.
@ast
Analysis of acquired resistanc ...... ss in advanced ovarian cancer.
@en
P2093
P2860
P1433
P1476
Analysis of acquired resistanc ...... ess in advanced ovarian cancer
@en
P2093
Catherine Collins
Kae Hashimoto
Maria Luz Jaramillo
Maureen D O'Connor-McCourt
Myriam Banville
Robert S Kerbel
William Cruz-Muñoz
P2860
P2888
P304
P356
10.1007/S10456-014-9422-9
P577
2014-02-26T00:00:00Z